NewsBlazeAU – Lifestyle
Author:
SQ Innovation
Trial Results Support At-Home Treatment of Edema in Heart Failure with Subcutaneous Furosemide as an Effective and Safe Alternative to Inpatient Hospital Care
May 11, 2026
Lasix® ONYU[1] Achieves CE Marking under EU Medical Device Regulation, Reaching a Critical Milestone Toward International Market Authorization; European Medicines Agency Confirms Eligibility for Centralized Procedure Review Based on Technical Innovation
April 28, 2026
Lasix® ONYU Now Available from Walmart Specialty Pharmacy for Home Delivery
April 21, 2026
SQ Innovation and FIS Announce Strategic Supply Agreement for Furosemide API
April 15, 2026